Cargando…

Vax-Plasma in Patients With Refractory COVID-19

Detalles Bibliográficos
Autores principales:	Ordaya, Eloy E., Abu Saleh, Omar M., Stubbs, James R., Joyner, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585589/ https://www.ncbi.nlm.nih.gov/pubmed/34996552 http://dx.doi.org/10.1016/j.mayocp.2021.11.001

Ejemplares similares

Reply to Boodman et al
por: Ordaya, Eloy E, et al.
Publicado: (2023)

Online ‘anti-vax’ campaigns and COVID-19: censorship is not the solution
por: Armitage, R.
Publicado: (2021)

In Reply — Micro-Thrombosis, Perfusion Defects, and Worsening Oxygenation in COVID-19 Patients: A Word of Caution on the Use of Convalescent Plasma
por: Klompas, Allan M., et al.
Publicado: (2021)

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality
por: Paneth, Nigel, et al.
Publicado: (2023)

“Let the Cat Out of the Heart”: Clinical Characteristics of Patients Presenting With Blood Culture-Negative Endocarditis Due to Bartonella Species
por: Ordaya, Eloy E, et al.
Publicado: (2023)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Strongyloidiasis complicated by gram-negative bacteremia and liver abscesses
por: Ordaya, Eloy E., et al.
Publicado: (2022)

Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
por: Nelli, F., et al.
Publicado: (2022)

Vax1 rs7078160 polymorphisms and non-syndromic cleft lip: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors
por: Juskewitch, Justin E., et al.
Publicado: (2021)

To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability
por: Roberts, Hannah A., et al.
Publicado: (2022)

Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung Injury
por: Juskewitch, Justin E., et al.
Publicado: (2021)

Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study
por: Nelli, F., et al.
Publicado: (2022)

Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
por: Ripoll, Juan G., et al.
Publicado: (2022)

Getting a Vaccine, Jab, or Vax Is More Than a Regular Expression. Comment on “COVID-19 Vaccine-Related Discussion on Twitter: Topic Modeling and Sentiment Analysis”
por: Cummins, Jack Alexander
Publicado: (2022)

751. Decoding a Decade: Temporal Trends of MIC Distribution of Antifungals Against Cryptococcus species From a Reference Laboratory
por: Ordaya, Eloy E, et al.
Publicado: (2022)

COVID-19, cults, and the anti-vax movement
por: Mylan, Sophie, et al.
Publicado: (2021)

High levels of TNFα in patients with COVID-19 refractory to tocilizumab
por: Danlos, F.X., et al.
Publicado: (2021)

COVID‐19‐vaccinated plasma treatment for COVID‐19 patients?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2021)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

HealVax
por: Foerster, John, et al.
Publicado: (2018)

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Onset of Remission Following COVID-19 Infection in a Patient with Refractory Lupus Nephritis
por: Sathiavageesan, Subrahmanian
Publicado: (2022)

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice
por: Patel, S, et al.
Publicado: (2015)

Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020)

Convalescent plasma (CP) therapy in patients with COVID-19
por: Cakir, Banu
Publicado: (2021)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

VAX Software Overview
por: DELPHI Collaboration
Publicado: (1982)

Central VAX upgrade
Publicado: (1987)

VAX support installation
por: Luque, Maria
Publicado: (2021)

274. Impact of Fungal Serologies in the Management of Veteran Patients with Suspected Endemic Mycoses
por: Ordaya, Eloy E, et al.
Publicado: (2019)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
por: Karnasuta, Chitraporn, et al.
Publicado: (2017)

Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination
por: Saito, Kei, et al.
Publicado: (2021)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Failure of plasma therapy in Covid-19
por: Sookaromdee, P., et al.
Publicado: (2021)

Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study
por: Nelli, F., et al.
Publicado: (2022)

Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis
por: Ordaya, Eloy E., et al.
Publicado: (2023)

A Case of Hypercalcemia and Antibiotic-Related Acute Kidney Injury Following Implantation of Antibiotic Impregnated Calcium Sulfate Beads
por: Challener, Douglas, et al.
Publicado: (2019)

A comparative analysis of anti-vax discourse on twitter before and after COVID-19 onset
por: Nasralah, Tareq, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r56pthr0qemsjjn8hbol68kpol